Factors that influence outcome in non-invasive and invasive treatment in polycystic liver disease patients

Table 1 Demographical data, extrahepatic cysts and comorbidity

N (Male/Female)	41 (7/34)
Age at diagnosis (range, yr)	47.8 ± 11.9 (27-82)
Mean diagnosis retard time (range, yr)	2.8 (0-9)
Mean follow up time (yr)	5.7
Familiar history of PLD	44%
Body mass index at diagnosis
≤ 25	41%
> 25-≤ 30	44%
> 30	15%
Largest cyst diameter (range, cm)	8.2 ± 4.9 (2-25)
Extrahepatic cysts
Renal cysts	68%
Pancreatic cysts	15%
Spleen cysts	8%
Ovary cysts	2%
Comorbidity
Arterial hypertension	46%
Chronic renal insufficiency	24%
Dyslipidemia	15%
Hypothyroidism	7%
Type 2 diabetes	5%
Gastroesophageal reflux	5%

Table 2 Outcome of PLD patients

Symptomatic patients at diagnosis	27 (66%)
Abdominal pain	15
Early satiety	12
Increase of abdominal perimeter	9
Nausea	3
Complications during follow up	9 (22%)
Cyst infection	5
Cyst hemorrhage	3
Cholangitis	1
Invasive treatment patients	19 (46%)
Open fenestration	12
Laparoscopic fenestration	4
Fenestration + hepatic resection	3
Overall symptoms recurrence	4 (17%)
Open fenestration	3
Laparoscopic fenestration	0
Fenestration + hepatic resection	1
Surgery complications	6 (32%)
Bleeding	3
Infection	2
Pain	1